Page last updated: 2024-08-24

gemcitabine and mangostin

gemcitabine has been researched along with mangostin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Dong, D; Dong, X; Fan, Y; Geng, Q; Hu, Y; Jing, J; Li, E; Shi, Y; Wang, C; Wu, Y	1

Other Studies

2 other study(ies) available for gemcitabine and mangostin

Article	Year
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades. Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:1 Topics: AMP-Activated Protein Kinases; Animals; Antimetabolites, Antineoplastic; Apoptosis; Biomarkers, Tumor; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Deoxycytidine; Drug Synergism; Drug Therapy, Combination; Gallbladder Neoplasms; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Lipogenesis; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Sterol Regulatory Element Binding Protein 1; Tumor Cells, Cultured; Xanthones; Xenograft Model Antitumor Assays	2020

Article

Year

In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.

Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023

α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades.

Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:1

Topics: AMP-Activated Protein Kinases; Animals; Antimetabolites, Antineoplastic; Apoptosis; Biomarkers, Tumor; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Deoxycytidine; Drug Synergism; Drug Therapy, Combination; Gallbladder Neoplasms; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Lipogenesis; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Sterol Regulatory Element Binding Protein 1; Tumor Cells, Cultured; Xanthones; Xenograft Model Antitumor Assays

2020